Endocyte, Inc. (ECYT) Posts Q1 Loss of 11c/Share

Endocyte, Inc. (NASDAQ: ECYT) reported Q1 EPS of ($0.11), $0.05 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $14.24 million.

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• Kolibri Global Energy Inc. (KGEI) Misses Q2 EPS by 2c
• Legence Corp. (LGN) Misses Q2 EPS by 58c